Merck & Co., Inc. Profit Falls After Schering-Plough Corporation Acquisition

Bloomberg -- Merck & Co., the second-largest U.S. drugmaker, reported a 79 percent drop in first-quarter profit on acquisition costs and projected 2010 earnings below what some analysts were expecting.

Back to news